Detalles de la búsqueda
1.
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 42(15): 1851-1860, 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452327
2.
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 42(5): 605-613, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127780
3.
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.
Clin Cancer Res
; 27(8): 2126-2129, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188141
4.
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer.
Clin Cancer Res
; 27(16): 4478-4485, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753456
5.
Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation.
FASEB J
; 22(11): 3878-87, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18676402
6.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.
Clin Cancer Res
; 23(23): 7165-7170, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751443
7.
FDA Approval: Blinatumomab.
Clin Cancer Res
; 21(18): 4035-9, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374073
8.
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 21(16): 3586-90, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275952
9.
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy.
Clin Cancer Res
; 21(19): 4257-61, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26187614
10.
Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary.
Clin Cancer Res
; 19(22): 6067-73, 2013 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24141628
11.
Successes and Challenges of PARP Inhibitors in Cancer Therapy.
Front Oncol
; 5: 222, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26528434
12.
Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective.
Nat Rev Drug Discov
; 14(4): 294, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25792260
Resultados
1 -
12
de 12
1
Próxima >
>>